Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Jul 5, 2022; 13(4): 57-66
Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.57
Table 1 Demographic, clinical, nutritional, and bone density characteristics of patients with ulcerative colitis
Variable
UC (n = 68)
Control (n = 66)
P value
Age (yr), median (IR)39.0 (31.0-44.8)36.5 (29.0-43.0)0.484
Sex (female), n (%)42 (61.8)39 (59.1)0.867
Smoking (yes), n (%)2 (2.9)4 (6.1)0.437
Regular physical activity (yes), n (%)16 (23.5)15 (22.7)1.000
Duration of illness (yes), median (IR)5.0 (2.0-8.0)
Disease remission (yes), n (%)66 (97.1)
Intestinal resection history (yes), n (%)2 (2.9)
Extent of disease, n (%)
Proctitis13 (19.1)
Left colitis25 (36.8)
Extensive colitis30 (44.1)
Use of glucocorticoids (yes), n (%)12 (17.6)
Use ≥ 3 mo (yes), n (%)8 (66.7)
Accumulated dose of glucocorticoids (g), median (IR)1.7 (1.2-2.5)
Calcium supplement (yes), n (%)3 (4.4)0 (0)0.245
Vit D supplement (yes), n (%)5 (7.4)0 (0)0.058
Serum calcium (mmol/L), median (IR)2.3 (2.2-2.4)2.4 (2.3-2.4)0.065
Serum albumin (g/dL), median (IR)4.3 (4.1-4.5)4.4 (4.1-4.6)0.801
C-RP mg/dL, median (IR)1.4 (0.6-5.2)5.0 (1.0-6.2)0.004
BMI (kg/m2), median (IR)23.7 (20.6-26.5)26.3 (22.8-29.0)0.16
BMI classification, n (%)0.020
Thinness5 (7.4)1 (1.5)
Eutrophy40 (58.8)26 (39.4)
Overweight16 (23.5)28 (42.4)
Obesity7 (10.3)11 (16.7)
WC (cm), median (IR)80.5 (72.0-89.1)84.6 (79.7-93.7)0.156
LBM (kg), median (IR)40.1 (34.5-49.4)41.5 (35.3-52.2)0.604
BF (kg), median (IR)17.8 (11.5-22.6)23.2 (17.8-28.4)0.001
BF (%), median (IR)32.9 (23.7-37.6)34.8 (28.1-42.3)0.168
TBF (kg), median (IR)8.6 (6.3-12.5)12.8 (7.8-16.5)0.354
BMD (g/cm2), median (IR)
Femoral neck0.99 (0.90-1.07)1.06 (0.96-1.15)0.120
Lumbar spine1.16 (1.08-1.26)1.21 (1.13-1.31)0.120
Total body1.17 (1.11-1.24)1.22 (1.19-1.290.000
Table 2 Demographic and clinical characteristics according to normal and low bone mineral density of patients with ulcerative colitis
Variable
Normal BMD (n = 40)
Low BMD (n = 28)
P value
Age (yr), median (IR)37.5 (30.0-43.0)40.0 (32.5-46.0)0.193
Age group, n (%)
< 45 yr31 (77.5)20 (71.4)0.57
≥ 45 yr9 (22.5)8 (28.6)
Sex, n (%)
Male11 (27.5)15 (53.6)0.03
Female29 (72.5)13 (46.4)
Regular physical activity, n (%)
No27 (67.5)25 (89.3)0.04
Yes13 (32.5)3 (10.7)
Duration of illness (yr), median (IR)5.0 (2.0-9.0)4.5 (1.2-6.7)0.98
Extent of disease, n (%)
Proctitis12 (30.0)1 (3.6)0.01
Left colitis11 (27.5)14 (50.0)
Extensive colitis17 (42.5)13 (46.4)
Use of glucocorticoids, n (%)
No33 (84.6)22 (78.6)0.75
Yes6 (15.4)6 (21.4)
Use of glucocorticoids ≥ 3 mo, n (%)
No3 (50.0)1 (16.7)0.54
Yes3 (50.0)5 (83.3)
Accumulated dose of glucocorticoids (g), median (IR)1.8 (1.3-2.3)1.5 (1.1-3.5)0.55
Serum calcium (mmol/L), median (IR)2.3 (2.3-2.4)2.2 (2.2-2.3)0.03
Serum albumin (g/dL), median (IR)4.4 (4.1-4.6)4.3 (4.0-4.5)0.57
PCR mg/dL, median (IR)3.1 (0.9-6.1)1.6 (1.6-6.3)0.56
Table 3 Prevalence and prevalence ratio of low bone mineral density according to demographic, clinical, and nutritional characteristics of patients with ulcerative colitis
VariablePrevalence of low BMD, n (%)
PR (95%CI)P value
Sex
Female1557.71.00
Male1331.01.86 (1.07 – 3.26)0.029
Age group
< 45 yr2039.21.00
≥ 45 yr847.11.38 (0.46 – 4.16)0.583
Regular physical activity
Yes318.81.00
No2548.12.56 (0.89 – 7.39)0.081
Steroid use
No2338.31.00
Yes562.51.63 (0.87 – 3.05)0.126
Steroid use
< 3 mo125.01.00
≥ 3 mo562.52.50 (0.42 – 14.8)0.313
BMI classification
Not overweight2351.11.00
Overweight521.70.43 (0.19 – 0.97)0.043
WC classification
Normal2152.51.00
Elevated623.10.44 (0.21 – 0.94)0.034
BF classification (%)
Normal1045.51.00
Elevated1839.10.86 (0.48 – 1.54)0.614